Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dataset wrap
Nametx.xpt Trial Sets
  • How do we handle "toxic, no revertant colonies"?  (LAK will add 6 records with GTSTAT = NOT DONE, GTREASND = "TOO MUCH CYTOTOXICITY,"
  • Condition of background bacterial lawn?  Slight thinning, Very thin? - refer to SEND team's marked-up table.
    • new Test code of Cytotoxicity with GTORRES = S, V (controlled terms)
    • Each plate we would have one result record for Revertent count and another for the lawn evaluation (NORMAL, SLIGHT THINNING, VERY THIN)
  • When "-" in Mean, Std Dev, Fold Inc - refer to SEND team's marked-up table (GTSTAT = NOT DONE; variety of REASND)
Rowcaps
Rows 1-22:Shows trial set parameters and trial set values that comprise the test conditions for the set SetA. SetA is the first row of the raw data table, see the row labeled "SetA" in the table, Raw Data for Study 8325064.
Rows 2-4:Show two records for Alkaline Phosphatase that were collected 1 day apart and are expected to be reported together. Row 4 shows how to create a derived record (average of the Rows 2 and 3) and flag it as Derived (LBDRVFL = "Y") as well as the record to use as baseline (LBBLFL = "Y").
Rows 6-7:Show a suggested use of the LBSCAT variable. It could be used to further classify types of tests within a laboratory panel (e.g., "DIFFERENTIAL").
Row 9:Shows the proper use of the LBSTAT variable to indicate "NOT DONE," when the fact that the test was done was documented.
Row 12:The subject had Cholesterol measured. The normal range for this test is <200 mg/dL. The value <200 may not be used in the normal range variables LBORNRHI or LBSTNRHI; however, a sponsor may decide, e.g., to enter "0" into LBORNRLO and "199" in LBORNRHI. The sponsor must define the appropriate value for all of the normal range variables.
Row 13:Shows the use of LBUSCHFL to indicate that the test result was obtained from an unscheduled blood collection. In this case, the subject was moribund and a blood sample was taken prior to sacrifice.
Rows 1, 6:Use records in the SUPPLB dataset example to show biological significance assigned by the investigator for test results.
Expand
titletx.xpt (trial sets)
RowSTUDYIDASSAYIDDOMAINSETCDSETTXSEQTXPARMCDTXPARMTXVAL
18325064AmesTX

SetA

A-TA98-C01SPECIESSpeciesSalmonella typhimurium
28325064AmesTXSetAA-TA98-C02STRAINStrain/SubstrainTA98
38325064AmesTX

SetA 

A-TA98-C03METACTMetabolic Activation  
48325064AmesTX

SetA 

A-TA98-C04METACTFLY/N presence of metabolic activationN
58325064AmesTXSetAA-TA98-C05TRTDMINTreatment Duration Minimum71.5
68325064AmesTXSetAA-TA98-C06TRTDTRGTreatment Duration Target72
78325064AmesTXSetAA-TA98-C07TRTDMAXTreatment Duration Maximum72.5
88325064AmesTXSetAA-TA98-C08TRTDUTreatment Duration UnitHOURS
98325064AmesTXSetAA-TA98-C09INCBTMPIncubation Temperature37
108325064AmesTXSetAA-TA98-C010INCBTMPUIncubation Temperature UnitC
118325064AmesTXSetAA-TA98-C011HUMIDAtmospheric Relative Humidity  Percent50
128325064AmesTXSetAA-TA98-C012ATMCO2Atmospheric CO2 Percent5
138325064AmesTXSetAA-TA98-C013SPTOBID

Sponsor defined tobacco identifier

CIG01a
148325064AmesTXSetAA-TA98-C014EXPTYP

Exposure Type (See TIG NC workstream minutes 30-Jan here: Nonclinical)

Submerged
158325064AmesTXSetAA-TA98-C015SAMTYP 

Sample Type

Total Particulate Matter in PBS
168325064AmesTXSetAA-TA98-C016INTRVN

name of the intervention article

TA1
178325064AmesTXSetAA-TA98-C017ITVTYPE

type of intervention article

Vehicle Control
188325064AmesTXSetAA-TA98-C018ITVCONCConcentration of intervention article0
198325064AmesTXSetAA-TA98-C019ITVCONCUConcentration Unitug/plate
208325064AmesTXSetAA-TA98-C020TRTVTreatment VehicleDMSO
218325064AmesTXSetAA-TA98-C021SPDEVIDSponsor defined device identifierPUFFMASTER3K
228325064AmesTXSetAA-TA98-C022DUREFIDSmoke RegimenMedium Intensity Regimen
238325064AmesTX

SetF

(row 6)

F-TA98-C5001SPECIESSpecies
248325064AmesTX

SetF

F-TA98-C5002STRAINStrain/Substrain
258325064AmesTX

SetF

F-TA98-C5003METACTMetabolic Activation  
268325064AmesTX

SetF

F-TA98-C5004METACTFLY/N presence of metabolic activationN
278325064AmesTXSetFF-TA98-C500
TRTDRTOLTreatment Duration Tolerance
288325064AmesTXSetFF-TA98-C500
TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)

8325064AmesTXSetFF-TA98-C500
INTRVN

name of the intervention article

(Tobacco ProdA, Bleomycin or Cyclophosphamid A)

TA1

8325064AmesTXSetFF-TA98-C500
ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Product

8325064AmesTXSetFF-TA98-C500
ITVCONCConcentration of intervention article500

8325064AmesTXSetFF-TA98-C500
ITVCONCUConcentration Unitug/plate

8325064AmesTXSetFF-TA98-C500
STRAINStrain/SubstrainTA98

8325064AmesTXSetFF-TA98-C500
REGIMESmoking RegimeISO Regime
...











































































































































8325064AmesTX

SetG (row 7) do G not I!!!



METACTMetabolic Activation  (should there be two parms? Presence, type)?None

8325064AmesTXSetG

TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)

8325064AmesTXSetG

TRTDRTOLTreatment Duration Tolerance

8325064AmesTXSetG

TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)

8325064AmesTXSetG

INTRVN

name of the intervention article

(Tobacco ProdA, Bleomycin or Cyclophosphamid A)

2-Nitrofluorine

8325064AmesTXSetG

ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Positive Control

8325064AmesTXSetG

ITVCONCConcentration of intervention article5

8325064AmesTXSetG

ITVCONCUConcentration Unitug/plate

8325064AmesTXSetG

REGIMESmoking RegimeISO
...


SetG





8325064AmesTX

SetR

(Row 18)



METACTMetabolic Activation  (should there be two parms? Presence, type)?None

8325064AmesTX

SetR



TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)

8325064AmesTXSetR

TRTDRTOLTreatment Duration Tolerance

8325064AmesTXSetR

TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)

8325064AmesTXSetR

INTRVN

name of the intervention article

(Tobacco ProdA, Bleomycin or Cyclophosphamid A)

4-Nitroquinoline-1-oxide

8325064AmesTXSetR

ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Positive Control

8325064AmesTXSetR

ITVCONCConcentration of intervention article2

8325064AmesTXSetR

ITVCONCUConcentration Unitug/plate

8325064AmesTXSetR

STRAINStrain/SubstrainTA98

8325064AmesTXSetR

REGIMESmoking RegimeISO
Dataset wrap
Nameou.xpt Observational and Experimental Unit Identifiers
Rowcaps
Row 1:Shows values collected for the set, SetA, as shown in the 
Rows 2-4:Show two records for Alkaline Phosphatase that were collected 1 day apart and are expected to be reported together. Row 4 shows how to create a derived record (average of the Rows 2 and 3) and flag it as Derived (LBDRVFL = "Y") as well as the record to use as baseline (LBBLFL = "Y").
Rows 6-7:Show a suggested use of the LBSCAT variable. It could be used to further classify types of tests within a laboratory panel (e.g., "DIFFERENTIAL").
Row 9:Shows the proper use of the LBSTAT variable to indicate "NOT DONE," when the fact that the test was done was documented.
Row 12:The subject had Cholesterol measured. The normal range for this test is <200 mg/dL. The value <200 may not be used in the normal range variables LBORNRHI or LBSTNRHI; however, a sponsor may decide, e.g., to enter "0" into LBORNRLO and "199" in LBORNRHI. The sponsor must define the appropriate value for all of the normal range variables.
Row 13:Shows the use of LBUSCHFL to indicate that the test result was obtained from an unscheduled blood collection. In this case, the subject was moribund and a blood sample was taken prior to sacrifice.
Rows 1, 6:Use records in the SUPPLB dataset example to show biological significance assigned by the investigator for test results.
Dataset2

ou.xpt. Observational and Experimental Units domain

Experimental unit - The unit to which the treatment is applied, eg. Test tube

Observational unit - The unit on which the response is measured. (This may not be the same as the experimental unit.)

Dataset2
RowSTUDYIDASSAYIDDOMAINSETCD (in TX)EUID OBUID  
18325064AmesOUSetA
VC1
2123MLAOUA14_-S9_C31.3_BVC2
3123MLAOUA14_-S9_C31.3_BVC3
4123MLAOUA1 4_-S9_C31.3_BTFT1
5123MLAOUA14_-S9_C31.3_BTFT2
6123MLAOUA14_-S9_C31.3_BTFT3
7123MLAOUA24_-S9_C500_BVC1
8123MLAOUA24_-S9_C500_BVC2
9123MLAOUA24_-S9_C500_BVC3
10123MLAOUA24_-S9_C500_BTFT1
11123MLAOUA24_-S9_C500_BTFT2
12123MLAOUA24_-S9_C500_BTFT3
Expand
titlegt.xpt (similar to LB)
Dataset wrap
Namegt.xpt
Rowcaps
Rows 1-7:Show values collected for the set, SetA. 
Rows 8-15:Shows values collected for the set, SetF.  
Rows 6-7:Show a suggested use of the LBSCAT variable. It could be used to further classify types of tests within a laboratory panel (e.g., "DIFFERENTIAL").
Rows 6,7,12,13, x,x,x,x:Show values collected (e.g., MEAN, STANDARD DEVIATION, and/or FOLD INCREASE) that apply to all of the observational units within the experimental unit, as show by OBUID = "ALL". 
Row 9:Shows the proper use of the LBSTAT variable to indicate "NOT DONE," when the fact that the test was done was documented.
Row 12:The subject had Cholesterol measured. The normal range for this test is <200 mg/dL. The value <200 may not be used in the normal range variables LBORNRHI or LBSTNRHI; however, a sponsor may decide, e.g., to enter "0" into LBORNRLO and "199" in LBORNRHI. The sponsor must define the appropriate value for all of the normal range variables.
Row 13:Shows the use of LBUSCHFL to indicate that the test result was obtained from an unscheduled blood collection. In this case, the subject was moribund and a blood sample was taken prior to sacrifice.
Rows 1, 6:Use records in the SUPPLB dataset example to show biological significance assigned by the investigator for test results.
Dataset2
RowSTUDYIDASSAYIDDOMAINTXSETCDEUIDOUIDGTSEQGTTESTCDGTTESTGTORRESGTORRESUGTCOLSRT (coll. summ. result type)GTSTRESCGTSTRESNGTSTRESUGTDTCGTMETHOD
18325064AmesGTSETA A0_11RPPRevertant Numbers Per Plate26COLONIES
2626COLONIES
2015-08-03

INSTRUMENT COUNTED

28325064AmesGTSETA A0_22RPPRevertant Numbers Per Plate35COLONIES
3535

2015-08-03
INSTRUMENT COUNTED
38325064AmesGTSETA A0_33RPPRevertant Numbers Per Plate39COLONIES
3939

2015-08-03
INSTRUMENT COUNTED
48325064AmesGTSETA A0_44RPPRevertant Numbers Per Plate35COLONIES
3535

2015-08-03

INSTRUMENT COUNTED

58325064AmesGTSETA A0_55RPPRevertant Numbers Per Plate30COLONIES
3030
2015-08-03INSTRUMENT COUNTED
68325064AmesGTSETA AALL6RPPRevertant Numbers Per Plate33.0COLONIESMEAN33.033.0


78325064AmesGTSETA AALL7RPPRevertant Numbers Per Plate5.0COLONIESSTANDARD DEVIATION5.05.0

INSTRUMENT COUNTED

88325064AmesGTSETF
5_11RPPRevertant Numbers Per Plate8

88

MANUALLY COUNTED
98325064AmesGTSETF
5_11









108325064AmesGTSETF 
5_22RPPRevertant Numbers Per Plate10

1010

MANUALLY COUNTED
118325064AmesGTSETF 
5_33RPPRevertant Numbers Per Plate12

1212

MANUALLY COUNTED
128325064AmesGTSETF
ALL6RPPMEANMean of Revertant Numbers Per Plate

10.0




10.0


10.0





138325064AmesGTSETF 
ALL7RPPSTDDVStandard Deviation of Revertant Numbers Per Plate2.0

2.02.0


148325064AmesGTSETF 
ALL8RPPFDINCFold Increase of Revertant Numbers Per Plate0.3

0.30.3


158325064AmesGTSETF 

9CYTOTOXCytotoxicityVery thin background bacterial lawn

V




8325064AmesGTSETI
5_11RPPRevertant Numbers Per Plate1104

11041104



8325064AmesGTSETI
5_22RPPRevertant Numbers Per Plate1037

10371037



8325064AmesGTSETI
5_33RPPRevertant Numbers Per Plate971

971971



8325064AmesGTSETI
ALL6RPPMEANMean of Revertant Numbers Per Plate

1037.3




1037.3


1037.3






8325064AmesGTSETI
ALL7RPPSTDDVStandard Deviation of Revertant Numbers Per Plate66.5

66.566.5



8325064AmesGTSETI
ALL8RPPFLDINCFold Increase of Revertant Numbers Per Plate31.4

31.431.4